Johnson & Johnson 2026 Q3 - Results - Earnings Call Presentation

Johnson & Johnson reported its third-quarter earnings, with revenue and earnings per share (EPS) beating analyst estimates.

The company's pharmaceutical segment drove growth, while consumer health and medical devices segments saw declines.

Want to stay up to date with the world events at sea or at home?